ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Tubocapsenolide A Overcomes Oxaliplatin Resistance in Colorectal Cancer by Targeting PLK1 to Impair CEP55-ESCRT-Associated Vesicular Damage Clearance.
Yueying Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.